CSIRO and 360BioLabs who have been successful in securing a CRC-P grant to develop an antibody based in vitro diagnostic for metastatic cancer

Congratulations to to BioMelbourne Network members – CSIRO and 360BioLabs – who have been successful in securing a CRC-P grant to develop an antibody based in vitro diagnostic for metastatic cancer. This is the first round of the new CRC-Project scheme, designed to support short term, industry-led collaborative research.

Successful CRC-P 1st Selection Round Projects can be found here.

 

Home

News & opinion

Member Directory

Events